2Ashley RA, Inman BA, Sebo TJ, et al. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer, 2006, 15:712-720.
3Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. JNCI, 2000, 92:205 -216.
4Henly DR, Farrow GM, Zincke H. Urachal cancer: role of conservative surgery. Urology, 1993,42:635-639.
5Cilento BG, Bauer SB, Retik AB, et al. Uraehal anomalies : defining the best diagnostic modality. Urology, 1998, 52: 120-122.
6Mengiardi B, Wiesner W, Stoffel F, et al. Case 44: Adenocarcinoma of the urachus. Radiology, 2002, 222:744-777.
7Siefker-Radtke AO, Gee J, Shen Y, et al. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience. J Urol, 2003, 169 : 1295-1298.
8Kojima Y, Yamada Y, Kamisawa H, et al. Complete response of a recurrent advanced urachal carcinoma treated by S-1/cisplatin combination chemotherapy. Int J Urol, 2006,13 : 1123-1125.
9Kawakami S, Kageyama Y, Yonese J, et al. Successful treatment of metastatic adenocarcinoma of the urachus: report of 2 cases with more than 10-year survival. Urology, 2001,58:462.
